Forbion hits €200m hard cap for one of Europe’s largest dedicated bioeconomy funds

Life sciences-focused venture capital major Forbion has reached its €200m hard cap for its debut BioEconomy Fund, which will target B2B solutions that replace unsustainable products with scalable, cost-effective alternatives.